Enhancing antitumor immunity via ROS-ERS and pyroptosis-induced immunogenic cell death in multiple myeloma
Background Few studies have focused on the development of multiple myeloma (MM)-specific immunotherapies. Tumor immunogenic cell death (ICD), triggered by damage-associated molecular patterns, may enhance MM-specific antitumor activity, offering a potential treatment strategy.Methods This study conf...
Saved in:
| Main Authors: | Rong Fu, Hao Wang, Chun Yang, Jia Song, Kai Ding, Liu Hui, Liu Zhaoyun, Xianghong Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/6/e011717.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Arsenic Trioxide Enhances the Efficacy of PD‐1 Inhibitors in Hepatocellular Carcinoma by Inducing Immunogenic Cell Death via the ROS/ERS Pathway
by: Xionghui Wang, et al.
Published: (2025-06-01) -
Nanoparticle-mediated celastrol ER targeting delivery amplify immunogenic cell death in melanoma
by: Fengling Wang, et al.
Published: (2025-05-01) -
Inhibition of PRC1 elicits immunogenic cell death by triggering ROS-dependent ER stress in colorectal cancer via the Wnt/β-catenin signaling pathway
by: Wei Wang, et al.
Published: (2025-08-01) -
Dual roles of IRE1α inhibition in reversing mitochondrial ROS-induced CD8+ T-cell senescence and exerting direct antitumor effects in multiple myeloma
by: Jingjing Wang, et al.
Published: (2025-05-01) -
VSV-CHIKV activates antitumor immunity by inducing pyroptosis in a melanoma model
by: Fan Wu, et al.
Published: (2025-05-01)